Proven Pathogenic Or Probably Pathogenic Tbr1 Variant clinical trials

Explore recruiting proven pathogenic or probably pathogenic tbr1 variant clinical trials.

Recruiting proven pathogenic or probably pathogenic tbr1 variant studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Proven Pathogenic Or Probably Pathogenic Tbr1 Variant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A pilot, multicentre, controlled, open-label study evaluating 24 months of lithium carbonate treatment in patients with TBR1-related neurocognitive disorder. ESALIT (Efficacy- Safety-Lithium-TBR1)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Proven Pathogenic Or Probably Pathogenic Tbr1 Variant trials by city

Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Toronto Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Vancouver Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Montreal Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Calgary Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Edmonton Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Ottawa Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Winnipeg Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Quebec City Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Hamilton Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Kitchener Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in London Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Halifax Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in New York Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Los Angeles Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Chicago Proven Pathogenic Or Probably Pathogenic Tbr1 Variant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease